Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 14, 2002

View Archived Issues

Novel 5-HT1B antagonists with utility in depression identified at GSK

New adenosine A1 agonists discovered by GSK researchers

Merck scientists present novel inhibitors of factor Xa and/or factor VIIa

Sankyo describes the isolation of new antifungal agents from Phoma sp.

Series of integrin antagonists for asthma and other disorders prepared at Merck & Co.

Cholesterol-lowering efficacy of SMP-500, a novel ACAT inhibitor, in hyperlipidemic hamsters

Oregovomab enhances killer T-cell responses in apoptotic ovarian cancer cells

Pretreatment of solid tumors with NHS76/PEP2 improves efficacy of chemotherapy in mice

Emodin accelerates pancreatic regeneration in acute pancreatitis in rats

Orally active 5-HT2C receptor agonist synthesized at Vernalis as potential antiobesity agent

SLV-314: neurochemical and behavioral effects detailed at Neuroscience 2002

Binding profile of atypical antipsychotic agent SM-13496

Exanta proves superior to routinely used enoxaparin for reducing risk of VTE in major surgery

Oprelvekin reported to increase platelet counts in hepatitis C patients

Potential novel use for PPARgamma agonists discussed at AASLD meeting

Improved safety profile reported for ribavirin prodrug viramidine

Potential use of the antisense oligonucleotide ISIS-14803 in chronic HCV

Commit lozenge approved by the FDA for over-the-counter sale

Drug safety announcement regarding Refludan

Seattle Genetics releases clinical and preclinical updates

Recombinant alpha 1-antitrypsin topical gel enters clinical trials

Accelerated approval plan for KRX-101

Johnson & Johnson to acquire OraPharma

Serono and Amgen sign license agreement for multiple sclerosis product

Vertex advances Aurora kinase inhibitor into preclinical development

Immtech International completes efficacy trials of DB-289

Phase II clinical trial initiated to evaluate the efficacy of 17beta-estradiol against restenosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...